Abstract
Inherited peripheral neuropathies are frequent neuromuscular disorders known for their clinical and genetic heterogeneity. In 33 families, we identified 8 mutations in HINT1 (encoding histidine triad nucleotide–binding protein 1) by combining linkage analyses with next-generation sequencing and subsequent cohort screening of affected individuals. Our study provides evidence that loss of functional HINT1 protein results in a distinct phenotype of autosomal recessive axonal neuropathy with neuromyotonia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Skre, H. Clin. Genet. 6, 98–118 (1974).
Hahn, A.F., Parkes, A.W., Bolton, C.F. & Stewart, S.A. J. Neurol. Neurosurg. Psychiatry 54, 230–235 (1991).
Brenner, C. Biochemistry 41, 9003–9014 (2002).
Bieganowski, P. et al. J. Biol. Chem. 277, 10852–10860 (2002).
Chou, T.F. et al. J. Biol. Chem. 282, 15137–15147 (2007).
Chou, T.F. & Wagner, C.R. J. Biol. Chem. 282, 4719–4727 (2007).
Weiske, J. & Huber, O. J. Biol. Chem. 281, 27356–27366 (2006).
Weiske, J. & Huber, O. J. Cell Sci. 118, 3117–3129 (2005).
Li, H., Zhang, Y., Su, T., Santella, R.M. & Weinstein, I.B. Oncogene 25, 713–721 (2006).
Dolot, R., Ozga, M., Krakowiak, A. & Nawrot, B. Acta Crystallogr. D Biol. Crystallogr. 67, 601–607 (2011).
Parks, K.P. et al. Physiol. Genomics 20, 12–14 (2004).
Ozga, M., Dolot, R., Janicka, M., Kaczmarek, R. & Krakowiak, A. J. Biol. Chem. 285, 40809–40818 (2010).
de Planell-Saguer, M., Schroeder, D.G., Rodicio, M.C., Cox, G.A. & Mourelatos, Z. Hum. Mol. Genet. 18, 2115–2126 (2009).
Butland, G. et al. Nature 433, 531–537 (2005).
Su, T. et al. Proc. Natl. Acad. Sci. USA 100, 7824–7829 (2003).
Acknowledgements
We are grateful to the study participants and their families for their cooperation. We thank A. Suls, N. Avonce, G. Milternberger-Milteny, B. Ramirez Escorcia, W. Glassee, E. Ydens and C. Claes for their expert help with some of the experiments; the VIB Genetic Service Facility for sequencing and cell maintenance support; and C. Brenner (University of Iowa) for providing the BY8-5c yeast strain. This work was supported by the University of Antwerp (in part by IWS BOF 2008 23064 to A.J. and P.D.J.); the Fund for Scientific Research–Flanders (to A.J., P.D.J. and V.T.); the Medical Foundation Queen Elisabeth (GSKE; to P.D.J. and V.T.); the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO; to A.J., P.D.J. and V.T.); the Methusalem Excellence Grant of the Flemish Government; the Association Belge Contre les Maladies Neuromusculaires (ABMM; to A.J., J.B., P.D.J. and V.T.); the VIB TechWatch Fund (to A.J. and P.D.J.), the Medizinische Forschungsfonds Tirol (MFF Tirol) (to S.L. and A.R.J.), the US National Institue of Neurological Disorders and Stroke (NINDS; R01NS075764, U54NS065712-03 and R01NS052767 to S.Z.), the Austrian Science Fond (FWF; P23223-B19 to M.A.-G.) and the Ministry of Science and Technology of the Republic of Serbia (17 3016 and 17 508 to V.M.R. and D.S.-P.). J.B., M.Z. and K.P. are supported by a PhD fellowship, and P. Van Damme is supported by a clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen). All patients or their legal representatives signed an informed consent form prior to enrollment. This study was approved by local institutional review boards.
Author information
Authors and Affiliations
Contributions
M.Z., J.B., V.M.R., A.R.J., P.D.J. and A.J. designed the study strategy. M.Z., E.F., S.L. and A.R.J. performed and analyzed genetic mapping. P.D.R. and B.-S.P. generated and performed primary analysis of next-generation sequencing data. M.Z., P.D.R. and A.R.J. analyzed next-generation sequencing data. M.Z., E.D.V. and S.L., performed mutational analysis in the cohorts of affected individuals. J.B., P.D.J. and V.M.R. supervised the clinical aspects of the study. J.B., J.N., Y.P., E.B., Z. Matur, V.G., I.T., M.A.-G., T.M., P. Van Damme, W.N.L., N.B., Z. Mitrovic, S.C.P., H.T., G.B., A.B.-M., S.T., D.S.-P., B.I., A.F.H., S.Z., V.M.R., A.R.J. and P.D.J. recruited subjects, gathered clinical data and contributed DNA samples. M.Z., L.A.-S., K.P., T.O., V.T., P. Van Dijck and A.J. designed and performed functional analyses. M.Z., J.B., L.A.-S., A.R.J., P.D.J. and A.J. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Note, Supplementary Methods, Supplementary Figures 1–4 and Supplementary Tables 1–4 (PDF 4448 kb)
Rights and permissions
About this article
Cite this article
Zimoń, M., Baets, J., Almeida-Souza, L. et al. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet 44, 1080–1083 (2012). https://doi.org/10.1038/ng.2406
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2406
This article is cited by
-
HINT1 neuropathy in Lithuania: clinical, genetic, and functional profiling
Orphanet Journal of Rare Diseases (2022)
-
Myasthenia gravis coexisting with HINT1-related motor axonal neuropathy without neuromyotonia: a case report
BMC Neurology (2022)
-
A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature
Acta Neurologica Belgica (2022)
-
HINT1 neuropathy in Norway: clinical, genetic and functional profiling
Orphanet Journal of Rare Diseases (2021)
-
Human HINT1 Mutant Proteins that Cause Axonal Motor Neuropathy Exhibit Anomalous Interactions with Partner Proteins
Molecular Neurobiology (2021)